Correlation Between Eurofins Scientific and Quantum Genomics
Can any of the company-specific risk be diversified away by investing in both Eurofins Scientific and Quantum Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eurofins Scientific and Quantum Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eurofins Scientific SE and Quantum Genomics SA, you can compare the effects of market volatilities on Eurofins Scientific and Quantum Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eurofins Scientific with a short position of Quantum Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eurofins Scientific and Quantum Genomics.
Diversification Opportunities for Eurofins Scientific and Quantum Genomics
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eurofins and Quantum is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Eurofins Scientific SE and Quantum Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Genomics and Eurofins Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eurofins Scientific SE are associated (or correlated) with Quantum Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Genomics has no effect on the direction of Eurofins Scientific i.e., Eurofins Scientific and Quantum Genomics go up and down completely randomly.
Pair Corralation between Eurofins Scientific and Quantum Genomics
Assuming the 90 days trading horizon Eurofins Scientific SE is expected to under-perform the Quantum Genomics. But the stock apears to be less risky and, when comparing its historical volatility, Eurofins Scientific SE is 9.77 times less risky than Quantum Genomics. The stock trades about -0.02 of its potential returns per unit of risk. The Quantum Genomics SA is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 10.00 in Quantum Genomics SA on August 29, 2024 and sell it today you would lose (2.79) from holding Quantum Genomics SA or give up 27.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Eurofins Scientific SE vs. Quantum Genomics SA
Performance |
| Timeline |
| Eurofins Scientific |
| Quantum Genomics |
Eurofins Scientific and Quantum Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eurofins Scientific and Quantum Genomics
The main advantage of trading using opposite Eurofins Scientific and Quantum Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eurofins Scientific position performs unexpectedly, Quantum Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Genomics will offset losses from the drop in Quantum Genomics' long position.| Eurofins Scientific vs. Sartorius Stedim Biotech | Eurofins Scientific vs. Teleperformance SE | Eurofins Scientific vs. Biomerieux SA | Eurofins Scientific vs. Dassault Systemes SE |
| Quantum Genomics vs. Poxel SA | Quantum Genomics vs. Biophytis SA | Quantum Genomics vs. Gensight Biologics SA | Quantum Genomics vs. OSE Pharma SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |